Aeon Formulations Private Limited - Due diligence report

A 360° intelligence report on Aeonf: trust score, financial health, credit view, compliance, directors, growth and distress signals - genera…

2008-11-17 Chennai, Tamil Nadu Active Unlisted Active Compliant
Share
AF Aeon Formulations Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Aeonf — 360° Intelligence Report

Generated from MCA filings & public records
59/100
Trust Score
Moderate

Aeonf is assessed as Moderate with a Trust Score of 59/100. Aeonf is an active private limited indian non-government company incorporated in 2008, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Aeon Formulations Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
48/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).

Charges position: 1 open (6.00 cr) · 2 satisfied (10.12 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Canara Bank1 48.0 cr
Others1 48.0 cr
Indian Bank1 48.0 cr
Compliance Score: 48/100 Caution Indicated
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: EPFO.
  • Litigation present in 2 court forum(s).
  • Delayed payments to MSME suppliers disclosed (398 disclosure(s)).
  • 5 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VIJAYARANI VAITHEESWARAN 01234567 Director 01/04/2018 6 yrs Approved
ARIARASUDHAN VAITHEESWARAN 01234567 Director 01/04/2018 6 yrs Approved
Sathyamurthy Jayavardhini 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
10 allotment(s) · 14 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Aeon Centrafrique Venture Limited Joint Ventures 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 17+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Compliance score is weak (48/100).
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.80 cr.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence55/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment28/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 6.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view40/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
24 Sep 2025
Last AGM held
Annual general meeting
11 Apr 2025
Director appointed
Sathyamurthy Jayavardhini (Additional Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
27 May 2024
Charge satisfied
Canara Bank
07 May 2024
Charge created
Others - 6.00 cr
07 May 2021
Securities allotted
500000 Equity Shares - 50.00 Lakh raised
22 Jan 2021
Securities allotted
500000 Equity Shares - 50.00 Lakh raised
21 Nov 2020
Director ceased
ARIARASUDHAN VAITHEESWARAN
31 Mar 2020
Share transfer (FY 2020)
15000.00000000 shares to EESUN ENTERPRISES INDIA PVT LTD
Director ceased
HASMUKHLAL VORA DHIRAJLAL
05 Mar 2020
Director appointed
ARIARASUDHAN VAITHEESWARAN (Director)
31 Mar 2019
Share transfer (FY 2019)
43000.00000000 shares to EESUN ENTERPRISES INDIA PVT LTD
Share transfer (FY 2019)
52460.00000000 shares to HASMUKHLAL D VORA
31 Mar 2018
Share transfer (FY 2018)
32000.00000000 shares to VIJAYARANI
Share transfer (FY 2018)
900.00000000 shares to SUMATHY
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
5 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 10 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dr. Edwin Medilabs Private Limited U24100PB2019PTC050368 Kurali, Punjab, India
Kewin Chemicals Private Limited U24110GJ1999PTC035567 Ahmadabad City, Gujarat, India
Dueful Healthcare Private Limited U85195RJ1995PTC009709 Jaipur, Rajasthan, India
Psyco Remedies Limited U24232PB2010PLC033653 Ludhiana, Punjab, India
Medion Biotech Private Limited U51909DL2012PTC234100 Delhi, Delhi, India
Siflon Drugs And Pharmaceuticals Private Limited U24239TG2006PTC048931 Hyderabad, Telangana, India
Scoat Pharma Private Limited U24239TG2006PTC049786 Hyderabad, Telangana, India
Moraya Global Limited U24110MH1994PLC076214 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Aeonf before audits and certifications: compliance score 48/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Aeonf: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Aeonf - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Aeonf pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Aeonf - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Aeonf an active company?

Aeonf has MCA status “Active” with a compliance score of 48/100 (Caution Indicated).

Is Aeonf financially healthy?

Aeonf has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Aeonf?

Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Aeonf?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Aeonf have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Aeonf up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 48/100 (Caution Indicated).

Is it risky to lend to Aeonf?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.